Daiichi Sankyo Company, Limited
OTC: DSNKY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Hiroyuki Okuzawa
- Employees
- 18,726
- Headquarters
- Tokyo, Japan
- IPO year
- 2008
- Market cap
- $30.8B
- Website
- https://www.daiichisankyo.com
Loading DSNKY…
Loading profile data…Frequently asked questions about DSNKY
What does Daiichi Sankyo Company, Limited (DSNKY) do?
Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise that encompasses the entire lifecycle of drug development, from pioneering research and development to manufacturing, importation, marketing, and worldwide distribution of its medicinal products. Its extensive and diverse portfolio features numerous key pharmaceutical offering...
Where does DSNKY trade?
Daiichi Sankyo Company, Limited (DSNKY) trades on the Other OTC.
What sector is DSNKY in?
Daiichi Sankyo Company, Limited (DSNKY) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Daiichi Sankyo Company, Limited?
Hiroyuki Okuzawa is the chief executive officer of Daiichi Sankyo Company, Limited (DSNKY).
Where is Daiichi Sankyo Company, Limited headquartered?
Daiichi Sankyo Company, Limited is headquartered in Japan.
Does DSNKY pay a dividend?
Yes — Daiichi Sankyo Company, Limited (DSNKY) paid a trailing twelve-month dividend of USD 0.49 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did DSNKY go public?
Daiichi Sankyo Company, Limited (DSNKY) completed its initial public offering in 2008.
Is DSNKY an ADR?
Yes — DSNKY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Daiichi Sankyo Company, Limited reporting and dividends follow the underlying issuer.